MoneyWorks4Me

The revenue for the March 2023 quarter is pegged at Rs. 68.43 millions, about 24.87% up against Rs. 54.80 millions recorded during the year-ago period.The Net Profit of the company registered a slight decline of -15.86% to Rs. 11.09  millions from Rs. 13.18 millions.A decline of 16.02 millions was observed in the OP in the quarter ended March 2023 from 18.40 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 68.43 54.80 24.87 197.86 215.26 -8.08 197.86 215.26 -8.08
Other Income 0.03 3.25 -99.08 0.15 4.91 -96.95 0.15 4.91 -96.95
PBIDT 16.02 18.40 -12.93 34.02 42.50 -19.95 34.02 42.50 -19.95
Interest 0.63 0.41 53.66 2.35 1.53 53.59 2.35 1.53 53.59
PBDT 15.39 17.99 -14.45 31.67 40.97 -22.70 31.67 40.97 -22.70
Depreciation 1.04 1.06 -1.89 4.33 4.16 4.09 4.33 4.16 4.09
PBT 14.35 16.93 -15.24 27.34 36.81 -25.73 27.34 36.81 -25.73
TAX 3.26 3.75 -13.07 6.15 12.49 -50.76 6.15 12.49 -50.76
Deferred Tax 0.09 0.00 0.00 0.09 3.37 -97.33 0.09 3.37 -97.33
PAT 11.09 13.18 -15.86 21.19 24.32 -12.87 21.19 24.32 -12.87
Equity 64.37 64.37 0.00 64.37 64.37 0.00 64.37 64.37 0.00
PBIDTM(%) 21.70 31.20 -30.44 15.89 18.26 -12.97 15.89 18.26 -12.97
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1225.15
Cipla 1389.90
Lupin 2066.00
Zydus Lifesciences 1217.70
View more..